Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Microbiol.

Sec. Food Microbiology

This article is part of the Research TopicProbiotic Potential: Lactic Acid Bacteria in Advancing Functional Foods and Health OutcomesView all articles

Probiotic Potential of Lactiplantibacillus plantarum LBK from Koumiss in Reducing Hyperuricemia through Gut Microbiota Modulation

Provisionally accepted
Panpan  ZhaoPanpan Zhao1Yibo  LuYibo Lu1Jianchun  XuJianchun Xu1Hui  ZhongHui Zhong1Qingqing  YanQingqing Yan1Zhifeng  FangZhifeng Fang1Zhexin  FanZhexin Fan1Qin  WangQin Wang2Yuhui  LiYuhui Li3Xian  WangXian Wang4*Baokun  LiBaokun Li1*
  • 1Shihezi University School of Food Science and Technology, Shihezi, China
  • 2Karamay lvcheng agricultural development co., Ltd, Karamay, China
  • 3Xinjiang Academy of Agricultural and Reclamation Science, Shihezi, China
  • 4Institute of Agricultural Quality Standards and Detection Technology, Xinjiang Academy of Agricultural Sciences, Urumqi, China

The final, formatted version of the article will be published soon.

ABSTRACT 1 Hyperuricemia, a metabolic disorder resulting from purine metabolic dysfunction, 2 poses a significant threat to public health. Probiotics, in particular lactic acid bacteria, 3 have the potential to exert therapeutic benefits in the treatment of some metabolic 4 diseases. In this study, 73 lactic acid bacteria were isolated from Koumiss, and their 5 ability to degrade inosine and guanosine, inhibit xanthine oxidase, and other 6 biological properties were assessed through in vitro experiments. The finds revealed 7 that L. plantarum LBK exhibited a significant inhibition of xanthine oxidase activity 8 compared to other strains. It demonstrated superior adherence to the cell surface and 9 tolerance to acid and bile salt compared to all other strains. Subsequently, the strain 10 with the highest overall performance was selected to investigate its potential to lower 11 uric acid in mice with hyperuricemia. Additionally, compared to the model (MOD) 12 group, uric acid, urea nitrogen, and creatinine levels in serum were significantly 13 decreased in the L. plantarum LBK high dose (H-LBK) group. At the same time, L. 14 plantarum LBK alleviated the pathological and inflammatory changes of liver and 15 kidney. L. plantarum LBK treatment acted on kidney gene expression. It up-regulated 16 the gene expression of ATP binding cassette subfamily G member 2 (ABCG2), and 17 down-regulated the gene expression of both uric acid transporter 1 (URAT1) and 18 glucose transporter 9 (GLUT9). 16S rRNA sequencing analysis revealed the effects of 19 L. plantarum LBK treatment on gut microbiota. This treatment decreased the 20

Keywords: Hyperuricemia, Koumiss, lactiplantibacillus plantarum, uric acid transporters, Gut Microbiota, Xanthine Oxidase

Received: 30 Sep 2025; Accepted: 10 Nov 2025.

Copyright: © 2025 Zhao, Lu, Xu, Zhong, Yan, Fang, Fan, Wang, Li, Wang and Li. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence:
Xian Wang, 190614262@qq.com
Baokun Li, libaokun1998@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.